z-logo
open-access-imgOpen Access
Initial Report From a Swedish High-volume Transplant Center After the First Wave of the COVID-19 Pandemic
Author(s) -
Marie Felldin,
John Mackay Søfteland,
Jesper Magnusson,
Jana Ekberg,
Kristjan Karason,
Andreas Schult,
Hillevi Larsson,
Mihai Oltean,
Vanda Friman
Publication year - 2020
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000003436
Subject(s) - medicine , hydroxychloroquine , immunosuppression , transplantation , pediatrics , disease , covid-19 , infectious disease (medical specialty)
Solid organ transplant (SOT) recipients may be more vulnerable to coronavirus disease 2019 (COVID-19). Data on the clinical course of COVID-19 in immunosuppressed patients are limited, and the optimal management strategy for these patients is yet unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here